Yohei Funakoshi

6PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunityMedical virologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 04, 2025
A phase II trial of nivolumab for patients with platinum-refractory recurrent or metastatic salivary gland cancer.

Yoshiaki Nagatani, Naomi Kiyota, Tomoko Yamazaki

|Jul 25, 2025
Humoral immunity after hematopoietic stem cell transplantation: evaluation by B-cell receptor repertoire analysis.

Sakuya Matsumoto, Yohei Funakoshi, Kimikazu Yakushijin

|Jun 23, 2023
Response to mRNA SARS-CoV-2 vaccination evaluated by B-cell receptor repertoire after tixagevimab/cilgavimab administration.

Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji

|Jan 04, 2022
Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibody.

Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji

Pageof 1